Regenerative Medicine Market By Product (Cell Therapy, Stem Cell Therapy, Cell- based Immunotherapy Products, Gene Therapy, Tissue Engineering), Therapeutic Area (Oncology, Musculoskeletal Disorders, Dermatology & Wound Care, Cardiovascular Diseases, Ophthalmology, Neurology), & Region for 2024-2031
Report ID: 7157|No. of Pages: 202
Regenerative Medicine Market By Product (Cell Therapy, Stem Cell Therapy, Cell- based Immunotherapy Products, Gene Therapy, Tissue Engineering), Therapeutic Area (Oncology, Musculoskeletal Disorders, Dermatology & Wound Care, Cardiovascular Diseases, Ophthalmology, Neurology), & Region for 2024-2031
Regenerative Medicine Market Valuation – 2024-2031
The rising burden of chronic diseases within the demographic group, especially the aging population, is the major factor driving the demand for regenerative medicine. According to the analyst from Verified Market Research, the Regenerative Medicine Market is estimated to reach a valuation of USD 173.49 Billion by 2031 over the forecast by subjugating the revenue of USD 32.71 Billion valued in 2024.
Technological advancements, particularly in 3D printing and gene editing, further bolster the market by enabling the development of innovative therapies. It enables the market to grow at a CAGR of 23.19% from 2024 to 2031.
Regenerative Medicine Market: Definition/ Overview
Regenerative medicine is a multidisciplinary field focused on the repair, replacement, or regeneration of damaged tissues and organs to restore normal function. It harnesses the body’s natural healing processes and utilizes various techniques, including stem cell therapy, tissue engineering, and biomaterials.
The goal is to address conditions that traditional treatments may not effectively resolve, such as degenerative diseases, traumatic injuries, and congenital defects. By promoting tissue regeneration and enhancing the body’s inherent repair mechanisms, regenerative medicine holds the promise of improving patient outcomes and quality of life. This innovative approach not only aims to heal but also seeks to create new tissues or organs in laboratory settings for implantation when natural healing is insufficient.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=7157
What are the Key Drivers Contributing to the Growth of the Regenerative Medicine Market?
The growth of the regenerative medicine market is being driven by several key factors. Increasing approvals for innovative therapies have been noted, with regulatory bodies actively endorsing the use of regenerative medicine for various medical conditions, thereby enhancing treatment options. Advancements in technology, such as stem cell research and tissue engineering, have been recognized as significant contributors to this growth, facilitating the development of more effective therapies.
Additionally, the rising incidence of chronic diseases has been reported, creating a greater demand for advanced treatment solutions. Government statistics indicate that investment in regenerative medicine surged to USD 2.1 Billion in the Asia-Pacific region in late 2023, reflecting a robust interest in this field. Furthermore, the growing focus on personalized medicine has been highlighted, as patients increasingly seek tailored treatments that align with their unique health profiles, thereby driving further market expansion.
How do Reimbursement Challenges Impact Patient Access to Regenerative Medicine Treatments?
Reimbursement challenges significantly impact patient access to regenerative medicine treatments. The misalignment between existing reimbursement frameworks and the high costs associated with these therapies often results in financial burdens for healthcare providers, leading to coverage gaps that delay patient access. For instance, it has been reported that many states lack formal coverage policies for new cell and gene therapies at launch, which can result in delays of 6 to 18 months as state agencies determine appropriate coverage criteria. This situation is particularly critical for patients with rare diseases who may not have the time to wait for such policies to be established. Government statistics indicate that over 40% of clinical trials for cell-based therapies experience delays due to stringent reimbursement requirements, further complicating access.
Additionally, the ambiguity in definitions and classifications used by Medicare and Medicaid creates uncertainty, making it difficult for hospitals to onboard these innovative therapies. As a result, many patients are left with the option of out-of-pocket payments or crowdfunding, which can significantly hinder timely treatment and overall market growth.
Category-Wise Acumens
How does Cell Therapy Contribute to the Overall Revenue of the Regenerative Medicine Market?
Cell therapy is significantly contributing to the overall revenue of the regenerative medicine market. It is estimated that this segment will account for 51.2% of the regenerative medicine market by 2024, driven by its transformative potential in treating various conditions, including cancer and chronic diseases. Government statistics indicate that approximately 6 out of 10 adults in the U.S. have at least one chronic condition, which has led to a surge in the adoption of cell therapies as effective treatment options.
The increasing number of clinical trials is also noteworthy; over 1,000 stem cell clinical trials were registered globally as of 2022, reflecting the scientific community’s focus on harnessing cell therapies for therapeutic purposes. Furthermore, the growing body of positive clinical outcomes associated with these therapies is enhancing their market appeal, thereby driving revenue growth in the regenerative medicine sector.
How is the Aging Population Contributing to the Dominance of Musculoskeletal Disorders in the Regenerative Medicine Sector?
The aging population is significantly contributing to the dominance of musculoskeletal disorders in the regenerative medicine sector. As life expectancy continues to rise globally, age-related conditions such as osteoporosis, osteoarthritis, and sarcopenia are becoming increasingly prevalent. Government statistics indicate that nearly 60% of adults aged 65 and older report experiencing chronic musculoskeletal issues, which often lead to reduced mobility and quality of life. The physiological changes associated with aging, including the deterioration of bone density and muscle mass, are being recognized as primary factors driving the incidence of these disorders.
Moreover, it has been reported that musculoskeletal disorders are among the leading causes of disability worldwide, placing a substantial burden on healthcare systems. With the increasing geriatric population, the demand for effective regenerative therapies targeting these conditions is expected to grow, highlighting the critical role that aging plays in shaping the regenerative medicine landscape.
Gain Access into Free Regenerative Medicine Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=7157
Country/Region-wise Acumens
What Factors Contribute to North America’s Leading Position in the Regenerative Medicine Market?
North America’s leading position in the regenerative medicine market is significantly attributed to several key factors. A robust healthcare infrastructure is recognized, which supports the development and commercialization of innovative therapies. Government statistics indicate that approximately 70% of healthcare spending in the U.S. is directed towards chronic disease management, highlighting the region’s focus on addressing prevalent health issues.
Additionally, substantial investments in research and development are being made, with the National Institutes of Health (NIH) reporting over $41 billion allocated to biomedical research in 2022, fostering advancements in regenerative technologies. Favorable regulatory frameworks are also noted; the U.S. Food and Drug Administration (FDA) has implemented accelerated approval pathways for regenerative therapies, streamlining the process for bringing new treatments to market. Furthermore, high healthcare expenditures and a growing demand for personalized medicine are driving the adoption of regenerative therapies, ensuring that North America remains at the forefront of this rapidly evolving field.
What Factors are Driving the Rapid Growth of the Regenerative Medicine Market in the Asia-Pacific Region?
The rapid growth of the regenerative medicine market in the Asia-Pacific region is being driven by several key factors. Increased government funding for research and development is recognized as a significant contributor, with notable investments such as the Rs. 8.13 crore (approximately USD 1 Million) allocated by the Government of India in February 2022 to support advanced stem cell research facilities across 40 institutions. Additionally, the rising prevalence of chronic diseases is being highlighted, as conditions like cardiovascular diseases are becoming more common among the aging population; approximately 60% of adults aged 65 and older in the region report chronic health issues.
The COVID-19 pandemic has also played a role, as regulatory approvals for stem cell therapies to treat COVID-related complications have accelerated interest and adoption in regenerative medicine. For instance, in September 2021, India’s Central Drugs Standard Control Organization approved a stem cell-based therapy trial for COVID-19 pneumonia treatment. Furthermore, improving healthcare infrastructure and increasing public awareness about regenerative therapies are enhancing access and stimulating market growth
Competitive Landscape
The regenerative medicine sector is a battleground for innovation, with established pharmaceutical giants competing for domination alongside dynamic startups. While large firms have extensive portfolios and established distribution networks, versatile startups provide innovative platforms and individualized treatments. This dynamic landscape offers ongoing evolution and ground-breaking discoveries, delivering an exciting ride for both investors and patients.
Some of the prominent players operating in the regenerative medicine market include:
- Johnson & Johnson
- Novartis
- Roche
- AbbVie
- Pfizer
- Vericel Corporation
- Cellular Dynamics International
- Editas Medicine
- Spark Therapeutics
- Bluebird bio
- Fate Therapeutics
- Autolus Therapeutics
- Tmunity Therapeutics
- Rocket Pharmaceuticals
- Carbios Therapeutics
- Regentis
- Cellular Bioengineering (CBE) Korea
- Athersys,
- ReNeuron
- Histogenics
Latest Developments
- In March 2023, Johnson & Johnson announced the acquisition of Taris Biomedical to enhance its capabilities in developing innovative treatments for urological conditions, including regenerative therapies.
- In September 2023, Roche launched a new platform for personalized cell therapy, allowing for the engineering of induced pluripotent stem cells (iPSCs) tailored to individual patient needs, enhancing treatment efficacy.
Report Scope
| Report Attributes | Details |
|---|---|
| Study Period | 2021-2031 |
| Growth Rate | CAGR of ~23.19% from 2024 to 2031 |
| Base Year for Valuation | 2024 |
| Historical Period | 2021-2023 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | Johnson & Johnson, Novartis, Roche, AbbVie, Pfizer, Vericel Corporation, Cellular Dynamics International, Editas Medicine, Spark Therapeutics, Bluebird bio, Fate Therapeutics, Autolus Therapeutics, Tmunity Therapeutics, Rocket Pharmaceuticals, Carbios Therapeutics, Regentis, Cellular Bioengineering (CBE) Korea, Athersys Inc., ReNeuron, Histogenics |
| Customization | Report customization along with purchase available upon request |
Regenerative Medicine Market, By Category
Product:
- Cell Therapy
- Stem cell Therapy
- Cell-based Immunotherapy Products
- Gene Therapy
- Tissue Engineering
Therapeutic Area:
- Oncology
- Musculoskeletal Disorders
- Dermatology & Wound Care
- Cardiovascular Diseases
- Ophthalmology
- Neurology
- Other applications
Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as a future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF THE GLOBAL REGENERATIVE MEDICINE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL REGENERATIVE MEDICINE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porter’s Five Force Model
4.4 Value Chain Analysis
5 GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT
5.1 Overview
5.2 Therapeutics
5.3 Cell Therapy
5.3.1 Stem cell Therapy
5.3.2 Cell Transplantations
5.4 Stem cell Therapy Products
5.5 Cell-based Immunotherapy Products
5.6 Gene Therapy
5.7 Tissue Engineering
6 GLOBAL REGENERATIVE MEDICINE MARKET, BY THERAPY AREA
6.1 Overview
6.2 Oncology
6.3 Musculoskeletal Disorders
6.4 Dermatology & Wound Care
6.5 Cardiovascular Diseases
6.6 Ophthalmology
6.7 Neurology
6.8 Other applications
7 GLOBAL REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 The U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 The U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Argentina
7.5.3 Rest of LATAM
7.6 Middle East and Africa
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Rest of the Middle East and Africa
8 GLOBAL REGENERATIVE MEDICINE MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
8.4 Company Regional Footprint
8.5 Company Industry Footprint
8.6 ACE Matrix
9 COMPANY PROFILES
9.1 Johnson & Johnson
9.1.1 Company Overview
9.1.2 Company Insights
9.1.3 Business Breakdown
9.1.4 Product Benchmarking
9.1.5 Key Developments
9.1.6 Winning Imperatives
9.1.7 Current Focus & Strategies
9.1.8 Threat from Competition
9.1.9 SWOT Analysis
9.2 Novartis
9.2.1 Company Overview
9.2.2 Company Insights
9.2.3 Business Breakdown
9.2.4 Product Benchmarking
9.2.5 Key Developments
9.2.6 Winning Imperatives
9.2.7 Current Focus & Strategies
9.2.8 Threat from Competition
9.2.9 SWOT Analysis
9.3 Roche
9.3.1 Company Overview
9.3.2 Company Insights
9.3.3 Business Breakdown
9.3.4 Product Benchmarking
9.3.5 Key Developments
9.3.6 Winning Imperatives
9.3.7 Current Focus & Strategies
9.3.8 Threat from Competition
9.3.9 SWOT Analysis
9.4 AbbVie
9.4.1 Company Overview
9.4.2 Company Insights
9.4.3 Business Breakdown
9.4.4 Product Benchmarking
9.4.5 Key Developments
9.4.6 Winning Imperatives
9.4.7 Current Focus & Strategies
9.4.8 Threat from Competition
9.4.9 SWOT Analysis
9.5 Pfizer
9.5.1 Company Overview
9.5.2 Company Insights
9.5.3 Business Breakdown
9.5.4 Product Benchmarking
9.5.5 Key Developments
9.5.6 Winning Imperatives
9.5.7 Current Focus & Strategies
9.5.8 Threat from Competition
9.5.9 SWOT Analysis
9.6 Vericel Corporation
9.6.1 Company Overview
9.6.2 Company Insights
9.6.3 Business Breakdown
9.6.4 Product Benchmarking
9.6.5 Key Developments
9.6.6 Winning Imperatives
9.6.7 Current Focus & Strategies
9.6.8 Threat from Competition
9.6.9 SWOT Analysis
9.7 Cellular Dynamics International
9.7.1 Company Overview
9.7.2 Company Insights
9.7.3 Business Breakdown
9.7.4 Product Benchmarking
9.7.5 Key Developments
9.7.6 Winning Imperatives
9.7.7 Current Focus & Strategies
9.7.8 Threat from Competition
9.7.9 SWOT Analysis
9.8 Editas Medicine
9.8.1 Company Overview
9.8.2 Company Insights
9.8.3 Business Breakdown
9.8.4 Product Benchmarking
9.8.5 Key Developments
9.8.6 Winning Imperatives
9.8.7 Current Focus & Strategies
9.8.8 Threat from Competition
9.8.9 SWOT Analysis
9.9 Spark Therapeutics
9.9.1 Company Overview
9.9.2 Company Insights
9.9.3 Business Breakdown
9.9.4 Product Benchmarking
9.9.5 Key Developments
9.9.6 Winning Imperatives
9.9.7 Current Focus & Strategies
9.9.8 Threat from Competition
9.9.9 SWOT Analysis
9.10 Bluebird bio
9.10.1 Company Overview
9.10.2 Company Insights
9.10.3 Business Breakdown
9.10.4 Product Benchmarking
9.10.5 Key Developments
9.10.6 Winning Imperatives
9.10.7 Current Focus & Strategies
9.10.8 Threat from Competition
9.10.9 SWOT Analysis
10 KEY DEVELOPMENTS
10.1 Product Launches/Developments
10.2 Mergers and Acquisitions
10.3 Business Expansions
10.4 Partnerships and Collaborations
11 Appendix
11.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
